Elana Araj

I'll research this attorney's professional background before drafting.

Let me verify the tracked cases and notable outcomes.

Elana B. Araj — Patent Litigation Practice Summary

Specialty / focus. Araj's docket is dominated by medical devices and life sciences: the Aerin Medical/The Foundry v. Neurent Medical litigation concerns radiofrequency devices for treating chronic rhinitis and nasal airway obstruction (D. Del. C.A. No. 23-756), and she has appeared for patent owner Globus Medical in a spinal-implant IPR and for Teleflex Medical in an intubation-patent appeal. Her Greenberg Traurig profile describes district court and PTAB practice across consumer products, health care, medical devices, and software, plus patentability/FTO opinions, utility and design prosecution, IP licensing, and privacy work. USPTO filing data also shows a substantial prosecution docket for large corporate filers (e.g., Capital One, GAF Energy, BMIC, GoDaddy, Broadridge). She also has trademark and copyright matters on her docket (e.g., Nanobebe v. Mayborn, JBrick v. Chazak per Law360). Her technical background is biological engineering (Cornell) with four years as a USPTO patent examiner, which fits the biotech/medical-device tilt.

Side preference. The tracked record is an even 4 plaintiff / 4 defendant, but that split is better read as caption posture than as a business model. Nearly all eight appearances arise from one intertwined medical-device dispute — Aerin Medical and The Foundry v. Neurent Medical, plus the related IPRs — where she appears for the patent-owner/plaintiff side (Aerin, The Foundry) in some filings and for Aerin as defendant to Neurent's counterclaims and separate suit in others. There is no indication of an NPE/PAE assertion practice; the pattern is defense and patent-owner representation of operating companies (Aerin/The Foundry, Globus Medical, Teleflex, and Moderna), not plaintiff-side assertion for a monetization entity.

Firm context. All tracked appearances are at Greenberg Traurig, LLP, where she is a Shareholder in the New York office (One Vanderbilt Avenue). No prior law-firm affiliation surfaced in the sources reviewed. Before law school she was a USPTO patent examiner (2007–2011) and an intern in Regeneron Pharmaceuticals' microarray department (2006).

Notable matters, PTAB, credentials. She is a frequent PTAB participant: back-up counsel on the Neurent-side petitions challenging Aerin/Foundry patents (IPR2024-00275–00282, 00669) and on Aerin's later petitions (IPR2025-01124–01127), and she argued the March 2024 oral hearing for patent owner Globus Medical in Life Spine v. Globus Medical, IPR2022-01600. In the 2024 Neurent IPRs she signed as attorney for patent owner The Foundry, a role that ended adversely — the Board found all challenged claims unpatentable in the July 2025 final written decisions (e.g., the '318, '011, and '077 patents), and Aerin's appeal is pending (Fed. Cir. No. 25-2099). Other reported results: Fed. Cir. declined to revive a physician's intubation patent suit against her client Teleflex Medical (2026), and IAM Patent 1000 credits the Greenberg team, including Araj, with successfully defending Moderna against Promosome's COVID-19 vaccine patent claims. Bar/admissions: New York and registered with the USPTO (Reg. No. 75,804); J.D., George Washington University Law School (2013); B.S., Biological Engineering, Cornell. Consistently identified via IAM Patent 1000 (Litigation, 2024–2026) and Best Lawyers "Ones to Watch"; the name is distinctive and the Greenberg Traurig/Reg. No. 75,804 identifiers are consistent across PTAB filings, so the risk of confusion with another attorney is low.